AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Internal Microstructure of Patent Foramen Ovale Related to Stroke

Recruitingn/aAges 16 Years - 65 YearsAllChina National Center for Cardiovascular Diseases
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study aims to (1) investigate the internal microstructure of patent foramen ovale related to cryptogenic stroke, transient ischemic attack or migraine and determine the effectiveness of transcatheter closure in these patients; (2) evaluate the microstructural features of asymptomatic patients with PFO and make a follow-up๏ผ›(3) perform an untargeted metabolomics analysis using plasma samples from right atrium and left atrium and shunt provocative test was conducted;(4) collect the blood sample from PFO tunnel;(5) cardiac CTA was performed to evaluate the position and morphology of device.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Patients aged 16 to 65 years without any known vascular risk factor, including hypertension, hypercholesterolemia, diabetes mellitus, atrial fibrillation, smoking and obesity; 2. Documented PFO with right-to-left shunt โ‰ฅ 20 micro-bubbles by c-TCD; 3. Stroke group: history of ischemic stroke (based on brain magnetic resonance imaging) or TIA within 6 months without other identifiable causes (Phase1); 4. Migraine group: history of migraine headaches more than one year without other identifiable causes (Phase2); 5. Control group: incidental finding of PFO without neurological or systemic symptoms (Phase3). Exclusion Criteria: 1. Any identifiable cause of ischemic stroke/TIA or migraine other than PFO; 2. History of stroke or TIA within the past one month; 3. Presence of cardiac enlargement or dysfunction; 4. Presence of coexisting cardiovascular structural malformations/diseases; 5. Presence of carotid artery lesions or coronary artery disease; 6. Presence of deep vein thrombosis or pulmonary embolism; 7. Presence of implanted cardiac devices; 8. Evidence of hypercoagulable state; 9. Allergic to contrast medium; 10. Echocardiographic evidence of intra-cardiac thrombus, mass, tumor or vegetation; 11. Active endocarditis or other infections.
๐Ÿ’Š

What it tests

  • not appliable
๐Ÿ“

Where

2 sites
Chaowu Yan
Beijing, China
National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences,Fuwai Hospital
Beijing, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy